share_log

Truist Securities Upgrades Astrana Health to Buy, Raises Price Target to $50

Benzinga ·  Jul 11 17:43

Truist Securities analyst Jailendra Singh upgrades Astrana Health (NASDAQ:ASTH) from Hold to Buy and raises the price target from $44 to $50.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment